Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup
A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, the company that popularized consumer genetic testing, could soon be delisted from the Nasdaq.
Renowned plant-based physician Dr. Michael Greger has released a new book on the risks, benefits, and alternatives to Ozempic ...
Lucrative weight loss drugs are new focus for diabetes patients The insulin supply shortages come as diabetes patients ...
Some fibers, like oat beta-glucans and wheat dextrin, are water- soluble, meaning they are easily fermented by gut bacteria.
First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...
To add more protein to your life, you can consider adding animal proteins like eggs, cottage cheese, Greek yogurt, and ...
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
Over the last year, weight loss medications such as GLP-1s (such as compounded semaglutide, Ozempic or Wegovy) have become ...
Early man first invented tools. Then he invented jewellery. Archeologists have discovered strings of shells, believed to have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback